Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

31 Jan 2019

Abstract excerpt

We have determined patient’s amyloid subtype through immunohistochemical and proteomic analyses of formalin-fixed, paraffin-embedded (FFPE) tissue samples from two affected organs per patient. Amyloid typing, via immunohistochemistry (IHC) and laser microdissection followed by the combination of liquid chromatography with mass spectrometry (LMD-LC-MS), was performed using tissue samples of the human heart, liver,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Caveolin-1 and cellular processes
Share to Drug Transport and Resistance Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30834260
DOI: 10.1155/2019/3689091

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ SitesPMID 30834260Read ↗

Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 SamplesSemantic proximity Read ↗

Assessing the Consistency of Mass Spectrometry, a Clinical-Laboratory Model, and Immunohistochemistry in Amyloid Subtyping: A Brazilian ExperienceSemantic proximity Read ↗

Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.Semantic proximity Read ↗

On Typing Amyloidosis Using Immunohistochemistry. Detailled Illustrations, Review and a Note on Mass SpectrometrySemantic proximity Read ↗

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.Semantic proximity Read ↗

New insights into systemic amyloidosis: the importance of diagnosis of specific type.Semantic proximity Read ↗

Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosisSemantic proximity Read ↗

Fibrinogen alpha amyloidosis: insights from proteomicsSemantic proximity Read ↗

Proteomic typing of amyloid deposits in systemic amyloidosesSemantic proximity Read ↗

The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatmentSemantic proximity Read ↗

Application of Omics Analysis in the Clinical Practice and Research of Transthyretin AmyloidosisSemantic proximity Read ↗

Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.